Publications

5891 Results

Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum

Authors
L Nappi;M Thi;A Lum;D Huntsman;B Eigl;C Martin;B O'Neil;B Maughan;K Chi;A So;P Black;M Gleave;A Wyatt;J Lavoie;D Khalaf;R Bell;S Daneshmand;R Hamilton;R Leao;C Nichols;C Kollmannsberger
Journal / Conference
Journal of Clinical Oncology, Nov 20;37 (33), 3090-3098
Year
2019
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID31553692
PMC
PMC7351323
Study Number(s)
S1823

Validation of plasma miR-371a-3p expression in patients with metastatic and early stage germ cell tumor

Authors
L Nappi;M Thi;A Lum;D Huntsman;B Eigl;K Chi;C Martin;B O'Neil;B Maughan;A So;P Black;M Gleave;A Wyatt;J Lavoie;D Khalaf;S Daneshmand;R Hamilton;R Leao;C Nichols;C Kollmannsberger
Journal / Conference
J Clin Oncol 37, 2019 (suppl 7S; abstr 526), poster; ASCO GU Cancers Symposium
Year
2019
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S1823

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial

Authors
E Stadtmauer;M Pasquini;B Blackwell;P Hari;A Bashey;S Devine;Y Efebera;S Ganguly;C Gasparetto;N Geller;M Horowitz;J Koreth;K Knust;H Landau;C Brunstein;P McCarthy;C Nelson;M Qasilbash;N Shah;D Vesole;R Vij;D Vogl;S Giralt;G Somlo;A Krishnan
Journal / Conference
Journal of Clinical Oncology Mar 1;37(7):589-597
Year
2019
Research Committee(s)
Myeloma
PMID
PMID30653422
PMC
PMC6553842
Study Number(s)
CTSU/CTN0702

On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance)

Authors
A Hatch;F-S Ou;T Zemla;M Starr;JC Brady;Y Liu;F Innocenti;J Meyerhardt;E O'Reilly;H-J Lenz;H Hurwitz;A Venook;AB Nixon
Journal / Conference
J Clin Oncol 37 (suppl 4; abstr 588); ASCO GI Cancers Symposium (Jan 17-19, 2019, San Francisco, CA), poster session
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study

Authors
J Foran;Z Sun;D Claxton;H Lazarus;D Arber;JM Rowe;E Paietta;J Racevskis;J Altman;S Luger;A Al-Kali;H Zheng;K Pratz;E Broun;B Powell;K O'Dwyer;J Godwin;Y Ofran;M Litzow;M Tallman
Journal / Conference
Blood (2019) 134 (Supplement_1): 115 (American Society of Hematology Annual Meeting (Dec 7-10, 2019, Orlando, FL)), oral
Year
2019
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E2906

Physician-Assisted Suicide (PAS)/Physician Aid in Dying (PAD) at the End of the Day [Narrative Oncology]l

Authors
MA O'Rourke
Journal / Conference
Practical Radiation Oncology Nov;9(6):384-386
Year
2019
PMID
PMID31525425

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415

Authors
M Thor;J Deasy;R Paulus;W Lee;M Amin;D Bruner;D Low;A Shah;S Malone;J Michalski;I Dayes;S Seaward;E Gore;M Albert;T Pisansky;S Faria;Y Chen;B Koontz;G Swanson;S Pugh;H Sandler
Journal / Conference
Radiotherapy and Oncology Jun;135:19-24; doi: 10.1016/j.radonc.2019.02.014. Epub 2019 Mar 5.
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID31015166
PMC
PMC6582638
Study Number(s)
CTSU/R0415

Clinical Work Intensity Among Medical Oncologists Practicing in National Community Oncology Research Program Community Sites

Authors
M Hudson;M O'Rourke;D Blackhurst;J Caldwell;R Horner
Journal / Conference
Journal of Oncology Practice 2019 Oct;15(10):e870-e877. doi: 10.1200/JOP.19.00132. Epub 2019 Jul 23.
Year
2019
PMID
31335248

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies

Authors
Watts, E. L.;Aurora Perez-Cornago;Paul N. Appleby;Demetrius Albanes;Eva Ardanaz;Amanda Black;H. Bas Bueno-de-Mesquita;June M. Chan;Chu Chen;S.A. Paul Chubb;Michael B. Cook;Mélanie Deschasaux;Jenny L. Donovan;Dallas R. English;Leon Flicker;Neal D. Freedman;Pilar Galan;Graham G. Giles;Edward L. Giovannucci;Marc J. Gunter;Laurel A. Habel;Christel Häggström;Christopher Haiman;Freddie C. Hamdy;Serge Hercberg;Jeff M. Holly;Jiaqi Huang;Wen-Yi Huang;Mattias Johansson;Rudolf Kaaks;Tatsuhiko Kubo;J. Athene Lane;Tracy M. Layne;Loic Le Marchand;Richard M. Martin;E. Jeffrey Metter;Kazuya Mikami;Roger L. Milne;Howard A. Morris;Lorelei A. Mucci;David E. Neal;Marian L. Neuhouser;Steven E. Oliver;Kim Overvad;Kotaro Ozasa;Valeria Pala;Claire H. Pernar;Michael Pollak;Mari-Anne Rowlands;Catherine A. Schaefer;Jeannette M. Schenk;Pär Stattin;Akiko Tamakoshi;Elin Thysell;Mathilde Touvier;Antonia Trichopoulou;Konstantinos K. Tsilidis;Stephen K. Van Den Eeden;Stephanie J. Weinstein;Lynne Wilkens;Bu B. Yeap;Timothy J. Key;Naomi E. Allen;Ruth C. Travis
Journal / Conference
Int J Cancer, 145(12), 3244-3256
Year
2019
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
30873591
PMC
6745281

Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018

Authors
Loree JM;Anand S;Dasari A;Unger JM;Gothwal A;Ellis LM;Varadhachary G;Kopetz S;Overman MJ;Raghav K
Journal / Conference
JAMA Oncol 2019 Oct 1;5(10):e191870. doi: 10.1001/jamaoncol.2019.1870. Epub 2019 Oct 10.
Year
2019
Research Committee(s)
Cancer Care Delivery
PMID
31415071
PMC
PMC6696743